Oncology Nursing News
Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!
Oncology Nursing News Top Stories: August 2023
In August 2023, a retrospective analysis suggest that bladder-sparing radiotherapy can yield survival outcomes that are equivalent to radical cystectomy in select patients with bladder cancer; the FDA granted accelerated approval to elranatamab-bcmm (Elrexfio) as a treatment for patients with relapsed or refractory multiple myeloma; and an …
News
An expanded analysis from the phase 3 CEPHEUS trial showed that daratumumab plus VRd improved MRD responses as well as progression-free survival among patients with transplant-ineligible or -deferred newly diagnosed multiple myeloma.
Daratumumab Monotherapy Shows Survival Benefit in Smoldering …
Dec 9, 2024 · Compared with active monitoring, subcutaneous daratumumab (Darzalex Faspro) led to significant progression-free survival (PFS) benefit in patients with intermediate- or high-risk smoldering multiple myeloma, according to primary results from the phase 3 AQUILA study (NCT03301220). 1-2 Further, the greatest PFS benefit was …
Oncology Nursing News Top Stories: April 2023
In April 2023, new research suggested that nurses may be able to extend the flush times for implanted vascular access devices; 4 gastrointestinal (GI) cancer specialists relayed their experiences in providing high quality care to patients with pancreatic cancer and cholangiocarcinoma; and findings from a study demonstrated that oncology nurses are well suited to encourage end-of-life ...
FDA Approves Ensartinib To Treat Frontline ALK+ NSCLC
6 days ago · Findings from the phase 3, randomized eXalt3 trial published in JAMA Oncology support this regulatory decision. The trial’s primary end point of progression-free survival (PFS) was met with ensartinib leading to a significantly longer median PFS than compared with crizotinib (Xalkori) at 25.8 months vs 12.7 months. 2 The confirmed intracranial response among patients with brain metastases ...
Oncology Nursing News Top Stories: January 2023
Feb 1, 2023 · Each month, Oncology Nursing News® takes a look back at our most popular stories.In January 2023, data presented at the 2022 San Antonio Breast Cancer Symposium continued to grab the attention of oncology nurses. Below, find links to poster presentations highlighting new innovations in tamoxifen-related symptom management, and an exclusive interview highlighting key nursing takeaways of ...
Oncology Nursing News
The FDA has approved zanubrutinib for patients with chronic lymphocytic leukemia or small lymphocytic lymphoma. The prescribing label comes with warnings for hemorrhage, infections, cytopenias, second primary malignancies, and cardiac arrythmias.
Oncology Nursing News: Top Stories from 2022
Dec 31, 2022 · In 2022, various emerging topics grabbed the attention of our readers, from the feasibility of using neoadjuvant chemotherapy to make organ-sparing surgery more accessible for patients with rectal cancer, to using bioimpedance spectroscopy to proactively preventing chronic lymphedema, to the use of oral Minoxidil to treat later-stage alopecia in survivors, nurses showed an interest in ...
Oncology Nursing News Top Stories: June 2023
Jun 30, 2023 · Each month, Oncology Nursing News® takes a look back at our most popular stories.